LOGO]Depositary Trust Agreement • November 28th, 2000 • Biotech Holdrs Trust • Blank checks
This prospectus supplement amends and supplements information contained in the prospectus dated November 22, 1999 relating to the sale of up to 1,000,000,000 depositary receipts by Biotech HOLDRS Trust.
BIOTECH HOLDERS TRUST AMENDMENT NO. 1 TO THE DEPOSITARY TRUST AGREEMENTDepositary Trust Agreement • August 15th, 2011 • Biotech Holdrs Trust • National commercial banks • New York
AMENDMENT NO. 1 TO THE DEPOSITARY TRUST AGREEMENT (this “Amendment”), dated as of August 11, 2011, between Merrill Lynch, Pierce, Fenner & Smith Incorporated, as initial depositor (the “Initial Depositor”), and The Bank of New York Mellon (formerly known as The Bank of New York), as trustee (the “Trustee”), all Depositors and all Owners and Beneficial Owners from time to time of Depositary Trust Receipts issued under the Depositary Trust Agreement referred to below.
EXCHANGE AGENT AGREEMENT (Biotech HOLDRS Trust)Exchange Agent Agreement • September 30th, 2011 • Market Vectors Etf Trust • New York
THIS EXCHANGE AGENT AGREEMENT (Biotech HOLDRs Trust) (this “Agreement”) between Market Vectors ETF Trust, a Delaware statutory trust (the “Offeror”), Van Eck Associates Corporation, a Delaware corporation (the “Parent”), and The Bank of New York Mellon, a New York banking corporation (the “Agent”), is dated as of _______________, 2011.
ARTICLE I DEFINITIONSAmendment No. 2 to the Standard Terms for Depositary Trust Agreements • November 28th, 2000 • Biotech Holdrs Trust • Blank checks • New York
